Roseola: Difference between revisions

Jump to navigation Jump to search
Damola (talk | contribs)
No edit summary
WikiBot (talk | contribs)
m Bot: Removing from Primary care
 
(14 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
'''For patient information click [[Roseola (patient information)|here]]'''
<small>
{{Infobox Disease |
{{Infobox Disease |
Name = Roseola |
Name = Roseola |
Line 5: Line 8:
Caption = Maculopapular rash as seen in an infant. |
Caption = Maculopapular rash as seen in an infant. |
}}
}}
</small>
{{Roseola}}
{{Roseola}}
{{CMG}}:{{AE}}{{DAMI}}
{{CMG}}:{{AE}}{{DAMI}}


{{SK}} Roseola infantum, exanthem subitum, sixth disease, 3- day rash, pseudorubella, exanthem criticum
{{SK}} Roseola infantum, exanthem subitum, sixth disease, 3 day rash, pseudorubella, exanthem criticum
==[[Roseola overview|Overview]]==
==[[Roseola overview|Overview]]==
Roseola is a disease of infants. It is characterized by an abrupt rise in body temperature to as high as 40°C (104°F) followed by a rapid drop to normal within the next 2–4 days which coincides with the appearance of an erythematous maculopapular skin rash that persists for 1–3 days. It is typically a beningn disease which resolves without sequale.


==[[Roseola historical perspective|Historical Perspective]]==
==[[Roseola historical perspective|Historical Perspective]]==
Human herpes virus which is the causative viral agent of roseola was first identified in 1986 in the peripheral blood leukocytes of patients who had HIV AIDS or a lymphoproliferative disorder.


==[[Roseola classification|Classification]]==
==[[Roseola classification|Classification]]==
There is no established classification system for roseola.


==[[Roseola pathophysiology|Pathophysiology]]==
==[[Roseola pathophysiology|Pathophysiology]]==
Line 33: Line 35:


==Diagnosis==
==Diagnosis==
[[Roseola history and symptoms|History and Symptoms]] | [[Roseola physical examination|Physical Examination]] | [[Roseola laboratory findings|Laboratory Findings]]
[[Roseola history and symptoms|History and Symptoms]] | [[Roseola physical examination|Physical Examination]] | [[Roseola laboratory findings|Laboratory Findings]] | [[Roseola  chest x ray|X Ray]] | [[Roseola CT|CT]] | [[Roseola MRI|MRI]] | [[Roseola other imaging findings|Other Imaging Findings]] | [[Roseola other diagnostic studies|Other Diagnostic Studies]]


==Treatment==
==Treatment==
[[Roseola medical therapy|Medical Therapy]]
[[Roseola medical therapy|Medical Therapy]] | [[Roseola surgery|Surgery]] | [[Roseola primary prevention|Primary Prevention]] | [[Roseola secondary prevention|Secondary Prevention]] | [[Roseola cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Roseola future or investigational therapies|Future or Investigational Therapies]]


==Case Studies==
==Case Studies==
[[Roseola case study one|Case #1]]
[[Roseola case study one|Case #1]]
[[Category:Emergency mdicine]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Neurology]]
[[Category:Pediatrics]]
[[Category:Dermatology]]

Latest revision as of 00:02, 30 July 2020

For patient information click here

Roseola
Maculopapular rash as seen in an infant.

Roseola Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Roseola from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Roseola On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Roseola

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Roseola

CDC on Roseola

Roseola in the news

Blogs on Roseola

Directions to Hospitals Treating Type chapter name here

Risk calculators and risk factors for Roseola

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]:Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]

Synonyms and keywords: Roseola infantum, exanthem subitum, sixth disease, 3 day rash, pseudorubella, exanthem criticum

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Any Disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1